Kathryn Woodburn
- Role
- Sr Vice President, Preclinical Development at Life Edit Therapeutics
- Location
- San Francisco, CA, US
- LinkedIn followers
- 500 followers
Experience
Sr Vice President, Preclinical Development
Aug 2021 — Present · Durham, NC, US
Life Edit is a next-generation gene editing company dedicated to paving the way to faster, safer, more innovative gene editing therapeutics that treat diseases once thought to be incurable. Our platform allows us to target any genomic sequence and develop life-changing therapies for the most challenging genetic disorders. Life Edit has one of the world’s largest and most diverse arrays of novel RNA-guided nucleases and base editors that are active in mammalian cells. They were developed from a proprietary collection of non-pathogenic organisms, and offer gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. Our genome editing platform is derived from AgBiome’s proprietary collection of tens of thousands of microbes. We retain access to this growing microbial collection to mine for gene editing systems with uses in human therapeutics.
Education
La Trobe University
PhD, Chemistry & Biochemistry Departments
The University of Toledo
Post Doctoral Research Fellow, Chemistry
Wayne State University School of Medicine
Post Doctoral Fellow, Pharmacology
La Trobe University
BSc (Hons), Chemistry & Biochemistry
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.